Conclusions
The MADIT II study and the SCD-HeFT studies suggest that the ICD reduces total mortality in patients with patients with LV dysfunction. However, the cost-effectiveness of this treatment makes it far from affordable. Better selection of patients that could benefit from an ICD might increase the cost-effectiveness and decrease the percentage of patients in whom an ICD will only produce inappropriate discharges and other undesirable effects. Subgroup analysis has demonstrated a progressive increase in effectiveness of the ICD as QRS duration increases. Little benefit was derived in patients with a QRS of less than 0.12 s, whereas if a QRS duration of 0.15 s was used as a cut-off, a marked reduction in SCD was observed, comparable to that in MUSTT and MADIT I. Similarly, in the SCD-HeFT trial the relative benefits of ICD therapy appeared greater in patients with NYHA class II heart failure, the group in which sudden death is expected to predominate. There seemed to be no benefit in patients with NYHA class III heart failure.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Moss AJ, Hall WJ, Cannom DS et al (1966) Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940
Buxton AE, Lee KL, Fisher JD et al (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890
Moss AJ, Zareba W, Hall WJ et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
Bardy GH, Lee KL, Mark DB et al (2004) Sudden Cardiac Death-Heart Failure Trial (SCD-HeFT). Paper presented at American College of Cardiology Annual Scientific Sessions, New Orleans 2004-Late Breaking Trial; 7–10 March 2004, New Orleans, LA
Reynolds MR, Josephson ME (2003) MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy. Circulation 108:1779–1783
Marti Almor J, Delclos Baulies M, Delclos Urges J et al (2004) Prevalence and clinical course of patients in Spain with acute myocardial infarction and severely depressed ejection fraction who meet the criteria for automatic defibrillator implantation. Rev Esp Cardiol 57:705–708
Ortiz M, Arenal A, González-Torrecilla E et al (2004) El desfibrilador automático implantable en la prevención primaria de la muerte súbita. ¿Existen diferencias entre los pacientes según los criterios de selección? Rev Esp Cardiol 57(Suppl 2):141
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this paper
Cite this paper
Arenal, A., Ortiz, M. (2005). MADIT II/SCD-HeFT Results: Have They Already Achieved an Impact in Europe?. In: Gulizia, M.M. (eds) Emerging Pathologies in Cardiology. Springer, Milano . https://doi.org/10.1007/88-470-0341-5_29
Download citation
DOI: https://doi.org/10.1007/88-470-0341-5_29
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0311-8
Online ISBN: 978-88-470-0341-5
eBook Packages: MedicineMedicine (R0)